| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |